Ainnocence Launches Self-Evolving, Multi-Objective AI Drug Discovery Platform
Ainnocence, a worldwide biotech firm on a mission to speed drug discovery through a quick, self-evolving AI drug design platform, made its debut today at the BIO International Convention in 2022. Ainnocence, which was founded by a diverse group of…